Your challenge: To understand the impact of allied health professionals and influencers on prescribers
Making clinical investment decisions for your early product candidates is risky business if you don’t know precisely what payers do and do not value, and how your choices will influence market access, pricing and reimbursement levels.
Are you:
- trying to balance the requirements of individual payer groups?
- formulating a robust pricing and reimbursement strategy?
- Understanding the drivers behind product reimbursement and uptake?
Our solution
94.8 provides advanced analytical modeling to help you fully understand the impact of your clinical investment decisions.
You’ll be able to:
- realize product adoption and pricing/reimbursement outcomes
- make effective trade-offs and informed based on hard facts
- model the adoption of your product across all elements of your Target Product Profile
- model the adoption of your emerging candidate and across a wide range of potential value drivers in your specific market
- accomplish the optimal value offering for payers across each of your target product candidates, countries and payer groups
- use 94.8 across your non-traditional customers, whether payers, pharmacists, patients, nurses or psychologists